KDL Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 12	Mar ' 11	Mar ' 10	Sep ' 08	Sep ' 07

Sources of funds

Owner's fund

Equity share capital

24.04

24.04

24.04

24.04

16.76

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-83.21

-66.00

-1.68

15.33

-9.34

Loan funds

Secured loans

50.87

50.84

37.82

44.70

33.96

Unsecured loans

0.55

0.46

19.55

19.55

48.91

Total

-7.75

9.34

79.72

103.61

90.29

Uses of funds

Fixed assets

Gross block

139.65

141.71

154.79

144.48

135.35

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

91.59

84.74

80.03

67.63

60.76

Net block

48.06

56.96

74.76

76.85

74.59

Capital work-in-progress

-

-

4.40

5.98

-

Investments

0.01

0.01

0.02

0.02

0.02

Net current assets

Current assets, loans & advances

8.63

8.38

26.84

50.79

93.66

Less : current liabilities & provisions

64.45

56.01

26.28

30.03

77.98

Total net current assets

-55.82

-47.63

0.55

20.76

15.68

Miscellaneous expenses not written

-

-

-

-

-

Total

-7.75

9.34

79.72

103.61

90.29

Notes:

Book value of unquoted investments

0.03

0.03

0.01

0.01

0.01

Market value of quoted investments

-

-

0.05

0.02

0.03

Contingent liabilities

90.96

92.81

13.32

3.14

2.62

Number of equity sharesoutstanding (Lacs)

240.35

240.35

240.35

240.35

167.62